Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Negative-pressure induced mechanical stimulation describes the application of controlled negative pressure (suction or vacuum) to tissues or cells to induce mechanical stress, with resulting biological and therapeutic effects. In clinical and preclinical settings, this approach is most commonly applied during negative pressure wound therapy (NPWT) or experimental protocols aiming to enhance cell proliferation, angiogenesis, osteogenic differentiation, and tissue remodeling. Mechanistically, negative pressure creates mechanical deformation, draws wound edges together, stimulates cell signaling pathways (such as those involving collagen type I, osteonectin, or sodium channel mechanosensitivity), and can induce favorable microenvironmental changes that promote healing, bone formation, or scar remodeling[1][2][3][4][6][7]. This is a procedure or modality, not a molecular target. This term should not be considered a canonical molecule or drug target; instead, it refers to a physical/mechanical intervention and thus should be flagged as incorrect in settings where a molecular target is required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Negative-pressure induced mechanical stimulation.